- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Clinical and Developmental Immunology
Volume 2012 (2012), Article ID 261470, 9 pages
Characterizing T Cells in SCID Patients Presenting with Reactive or Residual T Lymphocytes
1Cancer Research Center, Chaim Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University, 69978 Tel Aviv, Israel
2Hematology Laboratory, Chaim Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University, 69978 Tel Aviv, Israel
3Pediatric Immunology Service of Edmond and Lily Safra Children’s Hospital, Chaim Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University, 69978 Tel Aviv, Israel
4Department of Pediatric Hematology-Oncology, Hadassah Medical Center, Hadassah Hebrew University, 91120 Jerusalem, Israel
Received 13 June 2012; Revised 29 July 2012; Accepted 5 August 2012
Academic Editor: George N. Goulielmos
Copyright © 2012 Atar Lev et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- C. M. Roifman, R. Somech, and E. Grunebaum, “Matched unrelated bone marrow transplant for T+ combined immunodeficiency,” Bone Marrow Transplantation, vol. 41, no. 11, pp. 947–952, 2008.
- R. Elhasid and A. Etzioni, “Major histocompatibility complex class II deficiency: a clinical review,” Blood Reviews, vol. 10, no. 4, pp. 242–248, 1996.
- K. Aleman, J. G. Noordzij, R. De Groot, J. J. Van Dongen, and N. G. Hartwig, “Reviewing Omenn syndrome,” European Journal of Pediatrics, vol. 160, no. 12, pp. 718–725, 2001.
- S. Signorini, L. Imberti, S. Pirovano et al., “Intrathymic restriction and peripheral expansion of the T-cell repertoire in Omenn syndrome,” Blood, vol. 94, no. 10, pp. 3468–3478, 1999.
- A. Villa, L. D. Notarangelo, and C. M. Roifman, “Omenn syndrome: inflammation in leaky severe combined immunodeficiency,” Journal of Allergy and Clinical Immunology, vol. 122, no. 6, pp. 1082–1086, 2008.
- A. L. Appleton, A. Curtis, J. Wilkes, and A. J. Cant, “Differentiation of materno-fetal GVGD from Omenn's syndrome in pre-BMT patients with severe combined immunodeficiency,” Bone Marrow Transplantation, vol. 14, no. 1, pp. 157–159, 1994.
- S. M. Müller, M. Ege, A. Pottharst, A. S. Schulz, K. Schwarz, and W. Friedrich, “Transplacentally acquired maternal T lymphocytes in severe combined immunodeficiency: a study of 121 patients,” Blood, vol. 98, no. 6, pp. 1847–1851, 2001.
- C. Knobloch, S. F. Goldmann, and W. Friedrich, “Limited T cell receptor diversity of transplacentally acquired maternal T cells in severe combined immunodeficiency,” Journal of Immunology, vol. 146, no. 12, pp. 4157–4164, 1991.
- I. Tezcan, F. Ersoy, O. Sanal et al., “Long-term survival in severe combined immune deficiency: the role of persistent maternal engraftment,” Journal of Pediatrics, vol. 146, no. 1, pp. 137–140, 2005.
- N. Kobayashi, K. Agematsu, H. Nagumo et al., “Expansion of clonotype-restricted HLA-identical maternal CD4+ T cells in a patient with severe combined immunodeficiency and a homozygous mutation in the Artemis gene,” Clinical Immunology, vol. 108, no. 2, pp. 159–166, 2003.
- A. Plebani, M. Stringa, I. Priglione et al., “Engrafted maternal T cells in human severe combined immunodeficiency: evidence for a TH2 phenotype and a potential role of apoptosis on the restriction of T-cell receptor variable β repertoire,” Journal of Allergy and Clinical Immunology, vol. 101, no. 1, pp. 131–134, 1998.
- K. S. Denianke, I. J. Frieden, M. J. Cowan, M. L. Williams, and T. H. Mccalmont, “Cutaneous manifestations of maternal engraftment in patients with severe combined immunodeficiency: a clinicopathologic study,” Bone Marrow Transplantation, vol. 28, no. 3, pp. 227–233, 2001.
- R. Somech, A. J. Simon, A. Lev et al., “Reduced central tolerance in Omenn syndrome leads to immature self-reactive oligoclonal T cells,” Journal of Allergy and Clinical Immunology, vol. 124, no. 4, pp. 793–800, 2009.
- N. Amariglio, A. Hirshberg, B. W. Scheithauer et al., “Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient,” PLoS Medicine, vol. 6, no. 2, Article ID e1000029, 2009.
- P. L. Poliani, F. Facchetti, M. Ravanini et al., “Early defects in human T-cell development severely affect distribution and maturation of thymic stromal cells: possible implications for the pathophysiology of Omenn syndrome,” Blood, vol. 114, no. 1, pp. 105–108, 2009.
- P. Cavadini, W. Vermi, F. Facchetti et al., “AIRE deficiency in thymus of 2 patients with Omenn syndrome,” Journal of Clinical Investigation, vol. 115, no. 3, pp. 728–732, 2005.
- B. Cassani, P. L. Poliani, D. Moratto et al., “Defect of regulatory T cells in patients with Omenn syndrome,” Journal of Allergy and Clinical Immunology, vol. 125, no. 1–3, pp. 209–216, 2010.
- C. Picard and A. Fischer, “Hematopoietic stem cell transplantation and other management strategies for MHC class II deficiency,” Immunology and Allergy Clinics of North America, vol. 30, no. 2, pp. 173–178, 2010.
- V. R. Aluvihare, M. Kallikourdis, and A. G. Betz, “Regulatory T cells mediate maternal tolerance to the fetus,” Nature Immunology, vol. 5, no. 3, pp. 266–271, 2004.
- K. Arimoto, N. Kadowaki, T. Ishikawa, T. Ichinohe, and T. Uchiyama, “FOXP3 expression in peripheral blood rapidly recovers and lacks correlation with the occurrence of graft-versus-host disease after allogeneic stem cell transplantation,” International Journal of Hematology, vol. 85, no. 2, pp. 154–162, 2007.
- A. Fischer, “Severe combined immunodeficiencies (SCID),” Clinical & Experimental Immunology, vol. 122, pp. 143–149, 2000.